Plasma concentrations of sAxl are associated with severe preeclampsia

Clinical Biochemistry

Volumn 47, Issue 3, 2014, Pages 173-176

  Liu, Xijing ^a   Gong, Yunhui ^a   Jia, Jin ^a   Bai, Yi ^a   Gui, Shunping ^a   Wang, Tao ^a   Zhou, Rong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Axl Gas6 pathway; Preeclampsia; Soluble Axl; Vascular disease

Indexed keywords

PROTEIN TYROSINE KINASE; SAXL PROTEIN; SERUM ALBUMIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRTH WEIGHT; BODY MASS; CONTROLLED STUDY; DELIVERY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA; SEVERE PREECLAMPSIA; SYSTOLIC BLOOD PRESSURE;

AXL-GAS6 PATHWAY; PREECLAMPSIA; SOLUBLE AXL; VASCULAR DISEASE;

ADULT; BLOOD PRESSURE; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; PRE-ECLAMPSIA; PREGNANCY; PROTEINURIA; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84893770879     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.11.001     Document Type: Article

References (28)

1. Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009, 33:130-137.
2. Sibai B., Dekker G., Kupferminc M. Pre-eclampsia. Lancet 2005, 365:785-799.
3. Roberts J.M., Cooper D.W. Pathogenesis and genetics of pre-eclampsia. Lancet 2001, 357:53-56.
4. Lai C., Lemke G. An extended family of protein-tyrosine kinase genes differentially expressed in the vertebrate nervous system. Neuron 1991, 6:691-704.
5. O'Bryan J.P., Frye R.A., Cogswell P.C., Neubauer A., Kitch B., Prokop C., et al. Axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 1991, 11:5016-5031.
6. Hafizi S., Dahlback B. Gas6 and protein s. Vitamin k-dependent ligands for the axl receptor tyrosine kinase subfamily. FEBS J 2006, 273:5231-5244.
7. Fridell Y.W., Villa J., Attar E.C., Liu E.T. Gas6 induces Axl-mediated chemotaxis of vascular smooth muscle cells. J Biol Chem 1998, 273:7123-7126.
8. McCloskey P., Fridell Y.W., Attar E., Villa J., Jin Y., Varnum B., et al. Gas6 mediates adhesion of cells expressing the receptor tyrosine kinase Axl. J Biol Chem 1997, 272:23285-23291.
9. Nakano T., Higashino K., Kikuchi N., Kishino J., Nomura K., Fujita H., et al. Vascular smooth muscle cell-derived, gla-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J Biol Chem 1995, 270:5702-5705.
10. Bellosta P., Zhang Q., Goff S.P., Basilico C. Signaling through the ark tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation. Oncogene 1997, 15:2387-2397.
11. Goruppi S., Ruaro E., Varnum B., Schneider C. Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts. Mol Cell Biol 1997, 17:4442-4453.
12. Melaragno M.G., Fridell Y.W., Berk B.C. The Gas6/Axl system: a novel regulator of vascular cell function. Trends Cardiovasc Med 1999, 9:250-253.
13. Collett G.D., Sage A.P., Kirton J.P., Alexander M.Y., Gilmore A.P., Canfield A.E. Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells. Circ Res 2007, 100:502-509.
14. Korshunov V.A., Mohan A.M., Georger M.A., Berk B.C. Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res 2006, 98:1446-1452.
15. Cavet M.E., Smolock E.M., Menon P., Konishi A., Korshunov V.A., Berk B.C. Gas6-Axl pathway: the role of redox-dependent association of Axl with nonmuscle myosin IIb. Hypertension 2010, 56:105-111.
16. Craven R.J., Xu L.H., Weiner T.M., Fridell Y.W., Dent G.A., Srivastava S., et al. Receptor tyrosine kinases expressed in metastatic colon cancer. Int J Cancer 1995, 60:791-797.
17. Hutterer M., Knyazev P., Abate A., Reschke M., Maier H., Stefanova N., et al. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme. Clin Cancer Res 2008, 14:130-138.
18. Berclaz G., Altermatt H.J., Rohrbach V., Kieffer I., Dreher E., Andres A.C. Estrogen dependent expression of the receptor tyrosine kinase Axl in normal and malignant human breast. Ann Oncol 2001, 12:819-824.
19. Ito T., Ito M., Naito S., Ohtsuru A., Nagayama Y., Kanematsu T., et al. Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma. Thyroid 1999, 9:563-567.
20. Shieh Y.S., Lai C.Y., Kao Y.R., Shiah S.G., Chu Y.W., Lee H.S., et al. Expression of Axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia 2005, 7:1058-1064.
21. Gustafsson A., Martuszewska D., Johansson M., Ekman C., Hafizi S., Ljungberg B., et al. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival. Clin Cancer Res 2009, 15:4742-4749.
22. Ekman C., Stenhoff J., Dahlback B. Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood. J Thromb Haemost 2010, 8:838-844.
23. Cunningham F., Leveno K., Bloom S., Hauth J., Rouse D., Spong C. Pregnancy hypertension. In: Williams obstetrics 2010, p. 9256. McGraw-Hill, New York. 23rd ed.
24. George E.M., Granger J.P. Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens 2011, 24:964-969.
25. Gheita T.A., Bassyouni I.H., Bassyouni R.H. Plasma concentrations of growth arrest specific protein 6 and the soluble form of its tyrosine kinase receptor Axl in patients with systemic lupus erythematosus and Behcets disease. J Clin Immunol 2012, 32:1279-1286.
26. Ekman C., Jonsen A., Sturfelt G., Bengtsson A.A., Dahlback B. Plasma concentrations of Gas6 and sAxl correlate with disease activity in systemic lupus erythematosus. Rheumatology (Oxford) 2011, 50:1064-1069.
27. Ekman C., Gottsater A., Lindblad B., Dahlback B. Plasma concentrations of Gas6 and soluble Axl correlate with disease and predict mortality in patients with critical limb ischemia. Clin Biochem 2010, 43:873-876.
28. Ekman C., Linder A., Akesson P., Dahlback B. Plasma concentrations of Gas6 (growth arrest specific protein 6) and its soluble tyrosine kinase receptor sAxl in sepsis and systemic inflammatory response syndromes. Crit Care 2010, 14:R158.